Corporate Wellness Program
IV Infusions customized for your company and employees.
What we offer
Employee IV Treatment Customization
Wellness for your employees
Customizable Company Wide Plans
Office, Production, Gatherings, Retreats. Statistics show that the most successful companies create a culture of wellness, inclusivity, and ownership. Drip IV Therapy will customize your work experience to enhance productivity in your office. We are equipped to handle production / movie sets / editing bays, corporate settings, company retreats, etc.
Frequently Asked Questions
Corporate Wellness
The test detects the presence of SARS-CoV-2 RNA indicating that a person is infected and has COVID-19. A positive result indicates SARS-CoV-2 RNA has been detected in the upper respiratory tract sample submitted for testing. A negative result indicates that SARS-CoV-2 RNA was not detected in the respiratory sample.
This test requires an upper respiratory sample collected from individuals suspected of COVID-19 by healthcare providers (nasopharyngeal, oropharyngeal, nasal, or mid-turbinate swab collection).
A positive result indicates that SARS-CoV-2 RNA was detected and therefore the patient is infected and presumed to be contagious.A negative result indicates that SARS-CoV-2 RNA was not present in the specimen above the limit of detection. A negative result does not rule out COVID-19 and should not be used as the only basis for excluding the possibility of COVID-19.
We will send a nurse to your home where we will collect the specimen. The sample will then be sent to NKMax Health and you will be provided with your results within 48 to 72 hours.
In most cases, results will be available within 2-4 days from the time of specimen receipt. Results will be provided to the ordering physician. Patients can obtain test results by contacting their healthcare provider.
We do not currently accept health insurance. All tests are payable by credit card at time of service. An itemized receipt can be requested at time of payment which can be submitted to the patient’s insurance company for possible reimbursement.
